Boye Schnack Nielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Boye Schnack Nielsen has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Trine Møller
Molecular Histology
5 shared publications- Jaslin Pallikkunnath James
Department of Pathology, Herlev University Hospital, 2730 Herlev, Denmark
4 shared publications Jesper Larsen
4 shared publicationsKim Holmstrøm
Department of Cellular Engineering & Disease Modeling, Bioneer A/S, Kogle Allé 2, 2970 Hørsholm, Denmark
4 shared publications- Flemming Brandt Sørensen
Danish Colorectal Cancer Center South, Vejle Hospital, Vejle, Denmark
3 shared publications - Anders Jakobsen
Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark
2 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Elsevier in SSRN Electronic Journal
Cryopreservation of Bone Marrow Organoids
Bone marrow organoids (BMOs) derived from human induced pluripotent stem cells (hiPSCs) replicate key hematopoietic and stromal cell populations of the human bone marrow niche, providing a platform for disease modelling of hematological diseases. However, the 14–19-day differentiation process required for BMO generation limits their on-demand availability. We considered that cryopreservation of BMOs could address this bottleneck, and we therefore assessed controlled-rate cryopreservation of fully differentiated BMOs generated from four hiPSC lines (11599, BU3, Bioni10-C, and Bioni37-A) using a DMSO-based cryopreservation medium. Post-thaw viability, cellular composition, and organoid architecture were evaluated by flow cytometry and histological assessment after six days of recovery culture. Post-thaw viability was variable across the hiPSC lines and differentiation batches and did not consistently correlate with pre-cryopreservation viability, suggesting that biological factors intrinsic to individual differentiation runs are important determinants of cryopreservation outcome. BMOs derived from the 11599 hiPSC line showed the most consistent recovery, with post-thaw viability, cellular composition and organoid morphology comparable to pre-freeze conditions across three independent batches. These findings suggest that controlled-rate cryopreservation of fully differentiated BMOs is feasible and identify hiPSC line identity and differentiation batch quality as potential determinants of post-thaw recovery, supporting further development of BMO biobanking strategies.
- 9 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCryopreservation of Bone Marrow Organoids
Bone marrow organoids (BMOs) derived from human induced pluripotent stem cells (hiPSCs) replicate key hematopoietic and stromal cell populations of the human bone marrow niche, providing a platform for disease modelling of hematological diseases. However, the 14–19-day differentiation process required for BMO generation limits their on-demand availability. We considered that cryopreservation of BMOs could address this bottleneck, and we therefore assessed controlled-rate cryopreservation of fully differentiated BMOs generated from four hiPSC lines (11599, BU3, Bioni10-C, and Bioni37-A) using a DMSO-based cryopreservation medium. Post-thaw viability, cellular composition, and organoid architecture were evaluated by flow cytometry and histological assessment after six days of recovery culture. Post-thaw viability was variable across the hiPSC lines and differentiation batches and did not consistently correlate with pre-cryopreservation viability, suggesting that biological factors intrinsic to individual differentiation runs are important determinants of cryopreservation outcome. BMOs derived from the 11599 hiPSC line showed the most consistent recovery, with post-thaw viability, cellular composition and organoid morphology comparable to pre-freeze conditions across three independent batches. These findings suggest that controlled-rate cryopreservation of fully differentiated BMOs is feasible and identify hiPSC line identity and differentiation batch quality as potential determinants of post-thaw recovery, supporting further development of BMO biobanking strategies.
- Open Access
Molecular Sub‐Classification Suggests IBD Unclassified as a Distinct Subtype of Inflammatory Bowel Disease: Insights From a 3‐Gene Mucosal Signature
Differentiating Crohn's disease (CD) from ulcerative colitis (UC) is challenging, often resulting as Inflammatory bowel disease unclassified (IBDU). Based on targeted RNA sequencing, we recently reported a 3‐gene signature algorithm that distinguished CD from UC. This study evaluated its ability to classify IBDU cases and explore disease biology. We analyzed 197 mucosal FFPE biopsies (inflamed and non‐inflamed) from 113 individuals at diagnosis: CD ( n = 42), UC ( n = 41) and IBDU ( n = 102; follow‐up: 0–23 years (IQR)). Expression levels of ANXA1, PI3, and VDR mRNAs were measured by RT‐qPCR, and assessed using logistic regression, and ROC curve analysis. The algorithm discriminated CD from UC with AUC values > 0.70 in 6 out of 8 patient subsets, peaking in inflamed adult biopsies (0.78, 95% CI: 0.64–0.92). At 80% sensitivity, specificity ranged from 46% to 58%, replicating previous cohort findings and confirming reproducibility. Application of the algorithm to the IBDU cases showed low classification accuracy, with frequent misclassification of cases that were later received definitive diagnoses. Incorporation of additional IBDU‐specific features did not improve performance. While the 3‐gene signature algorithm demonstrates moderate ability to distinguish CD from UC, its limited performance in IBDU cases highlights fundamental constraints of binary classification approaches in IBD.
Open AccessMolecular Sub‐Classification Suggests IBD Unclassified as a Distinct Subtype of Inflammatory Bowel Disease: Insights From a 3‐Gene Mucosal Signature
Differentiating Crohn's disease (CD) from ulcerative colitis (UC) is challenging, often resulting as Inflammatory bowel disease unclassified (IBDU). Based on targeted RNA sequencing, we recently reported a 3‐gene signature algorithm that distinguished CD from UC. This study evaluated its ability to classify IBDU cases and explore disease biology. We analyzed 197 mucosal FFPE biopsies (inflamed and non‐inflamed) from 113 individuals at diagnosis: CD ( n = 42), UC ( n = 41) and IBDU ( n = 102; follow‐up: 0–23 years (IQR)). Expression levels of ANXA1, PI3, and VDR mRNAs were measured by RT‐qPCR, and assessed using logistic regression, and ROC curve analysis. The algorithm discriminated CD from UC with AUC values > 0.70 in 6 out of 8 patient subsets, peaking in inflamed adult biopsies (0.78, 95% CI: 0.64–0.92). At 80% sensitivity, specificity ranged from 46% to 58%, replicating previous cohort findings and confirming reproducibility. Application of the algorithm to the IBDU cases showed low classification accuracy, with frequent misclassification of cases that were later received definitive diagnoses. Incorporation of additional IBDU‐specific features did not improve performance. While the 3‐gene signature algorithm demonstrates moderate ability to distinguish CD from UC, its limited performance in IBDU cases highlights fundamental constraints of binary classification approaches in IBD.
- 2 August 2026
- Published by Springer Nature
- p. 207-220
LNA-Probe-Based MicroRNA In Situ Hybridization in Brain Organoids
- 2 August 2026
- Published by Springer Nature
- p. 207-220
LNA-Probe-Based MicroRNA In Situ Hybridization in Brain Organoids
- Open Access
- 31 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (10) , 12736-12746
Application of microRNA In Situ Hybridization on Long-term Stored Human Formalin-fixed Paraffin-embedded Brain Samples from Psychiatric Patients
Here, we report that long-term stored human brain samples, formalin-fixed paraffin-embedded (FFPE) from The Brain Collection, University of Southern Denmark, Denmark (https://www.sdu.dk/en/forskning/bridge/the-brain-collection), can be used for in situ hybridization (ISH) analysis of selected microRNAs (miRNAs). The Human Brain Collection consists of brains from 9479 subjects who died at a Danish State Mental Hospital in the period of 1945–1982. In the present study we included tissue specimens from prefrontal cortex (PFC) and hippocampus (HIP) from 163 patients diagnosed with schizophrenia, bipolar disorder, or major depressive disorder. Initially, the Nanostring nCounter platform was used to identify miRNA candidates for ISH analysis using the miRNAscope technology. Based on the Nanostring nCounter quantifications with bulk tissue, we identified and selected 10 miRNAs from PFC (miR-9-5p, miR-29b-3p, miR-30c-5p, miR-124-3p, miR-125b-5p, miR-138-5p, miR-181a-5p, miR-224-5p, miR-302d-3p, and miR-432-5p) and 6 miRNAs from HIP (let-7a-5p, miR-7-5p, miR-124-3p, miR-127-3p, miR-145-5p and miR-149-5p). miRNAscope ISH analysis was then performed with the respective probes on 30 PFC and 30 HIP samples, respectively. In the PFC six miRNAs (miR-9-5p, miR-29b-3p, miR-124-3p, miR-125b-5p, miR-138-5p, and miR-181a-5p) were detected and four (miR-145-5p, let-7a-5p, miR-124-3p and miR-7-5p) in the HIP samples. In both brain regions miR-124-3p was the most abundantly expressed. We conclude, that the combination of the Nanostring nCounter technology and the miRNAscope analysis is a valid approach to study spatial expression of specific miRNAs in these up to 76 years old FFPE blocks. This opens a new avenue of possibilities for studying the underlying epigenetic mechanisms in mental disorders.
- 31 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (10) , 12736-12746
Open AccessApplication of microRNA In Situ Hybridization on Long-term Stored Human Formalin-fixed Paraffin-embedded Brain Samples from Psychiatric Patients
Here, we report that long-term stored human brain samples, formalin-fixed paraffin-embedded (FFPE) from The Brain Collection, University of Southern Denmark, Denmark (https://www.sdu.dk/en/forskning/bridge/the-brain-collection), can be used for in situ hybridization (ISH) analysis of selected microRNAs (miRNAs). The Human Brain Collection consists of brains from 9479 subjects who died at a Danish State Mental Hospital in the period of 1945–1982. In the present study we included tissue specimens from prefrontal cortex (PFC) and hippocampus (HIP) from 163 patients diagnosed with schizophrenia, bipolar disorder, or major depressive disorder. Initially, the Nanostring nCounter platform was used to identify miRNA candidates for ISH analysis using the miRNAscope technology. Based on the Nanostring nCounter quantifications with bulk tissue, we identified and selected 10 miRNAs from PFC (miR-9-5p, miR-29b-3p, miR-30c-5p, miR-124-3p, miR-125b-5p, miR-138-5p, miR-181a-5p, miR-224-5p, miR-302d-3p, and miR-432-5p) and 6 miRNAs from HIP (let-7a-5p, miR-7-5p, miR-124-3p, miR-127-3p, miR-145-5p and miR-149-5p). miRNAscope ISH analysis was then performed with the respective probes on 30 PFC and 30 HIP samples, respectively. In the PFC six miRNAs (miR-9-5p, miR-29b-3p, miR-124-3p, miR-125b-5p, miR-138-5p, and miR-181a-5p) were detected and four (miR-145-5p, let-7a-5p, miR-124-3p and miR-7-5p) in the HIP samples. In both brain regions miR-124-3p was the most abundantly expressed. We conclude, that the combination of the Nanostring nCounter technology and the miRNAscope analysis is a valid approach to study spatial expression of specific miRNAs in these up to 76 years old FFPE blocks. This opens a new avenue of possibilities for studying the underlying epigenetic mechanisms in mental disorders.
- Open Access
- 14 May 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 449 (2) , 114604
Novel approaches to 3D cancer heterospheroid culture and assay development for immunotherapy screening
- 14 May 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 449 (2) , 114604
Open AccessNovel approaches to 3D cancer heterospheroid culture and assay development for immunotherapy screening
- Open Access
- 1 July 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1386097
Architectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing
3D cancer cell cultures have enabled new opportunities for replacing compound testing in experimental animals. However, most solid tumors are composed of multiple cell types, including fibroblasts. In this study we developed multicellular tumor heterospheroids composed of cancer and fibroblasts cell lines. We developed heterospheroids by combining HT-29, MCF-7, PANC-1 or SW480 with 1BR.3.G fibroblasts, which we have previously reported support spheroid formation. We also tested fibroblast cell lines, MRC-5, GM00498 and HIF, but 1BR.3.G was found to best form heterospheroids with morphological similarity to in vivo tumor tissue. The architectural organization of heterospheroids was based on histological examination using immunohistochemistry. We found that HT-29 and MCF-7 cells developed spheroids with the cancer cells surrounding the fibroblasts, whereas PANC-1 cells interspersed with the fibroblasts and SW480 cells were surrounded by fibroblasts. The fibroblasts also expressed collagen-1 and FAP-α, and whole transcriptomic analysis (WTA) showed abundant ECM- and EMT-related expression in heterospheroids, thus reflecting a representative tumor-like microenvironment. The WTA showed that PANC-1 heterospheroids possess a strong EMT profile with abundant Vimentin and CDH2 expression. Drug testing was evaluated by measuring cytotoxicity of 5FU and cisplatin using cell viability and apoptosis assays. We found no major impact on the cytotoxicity when fibroblasts were added to the spheroids. We conclude that the cancer cell lines together with fibroblasts shape the architectural organization of heterospheroids to form tumor-like morphology, and we propose that the various 3D tumor structures can be used for drug testing directed against the cancer cells as well as the fibroblasts.
- 1 July 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1386097
Open AccessArchitectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing
3D cancer cell cultures have enabled new opportunities for replacing compound testing in experimental animals. However, most solid tumors are composed of multiple cell types, including fibroblasts. In this study we developed multicellular tumor heterospheroids composed of cancer and fibroblasts cell lines. We developed heterospheroids by combining HT-29, MCF-7, PANC-1 or SW480 with 1BR.3.G fibroblasts, which we have previously reported support spheroid formation. We also tested fibroblast cell lines, MRC-5, GM00498 and HIF, but 1BR.3.G was found to best form heterospheroids with morphological similarity to in vivo tumor tissue. The architectural organization of heterospheroids was based on histological examination using immunohistochemistry. We found that HT-29 and MCF-7 cells developed spheroids with the cancer cells surrounding the fibroblasts, whereas PANC-1 cells interspersed with the fibroblasts and SW480 cells were surrounded by fibroblasts. The fibroblasts also expressed collagen-1 and FAP-α, and whole transcriptomic analysis (WTA) showed abundant ECM- and EMT-related expression in heterospheroids, thus reflecting a representative tumor-like microenvironment. The WTA showed that PANC-1 heterospheroids possess a strong EMT profile with abundant Vimentin and CDH2 expression. Drug testing was evaluated by measuring cytotoxicity of 5FU and cisplatin using cell viability and apoptosis assays. We found no major impact on the cytotoxicity when fibroblasts were added to the spheroids. We conclude that the cancer cell lines together with fibroblasts shape the architectural organization of heterospheroids to form tumor-like morphology, and we propose that the various 3D tumor structures can be used for drug testing directed against the cancer cells as well as the fibroblasts.
- Open Access
- 19 May 2022
- Published by Elsevier in Reproductive Toxicology
- Vol. 111, 68-80
Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies
- 19 May 2022
- Published by Elsevier in Reproductive Toxicology
- Vol. 111, 68-80
Open AccessHuman iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , 2449-2458
Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , 2449-2458
Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
- Open Access
Monocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer Models
Tumor-associated macrophages often correlate with tumor progression, and therapies targeting immune cells in tumors have emerged as promising treatments. To select effective therapies, we established an in vitro 3D multicellular spheroid model including cancer cells, fibroblasts, and monocytes. We analyzed monocyte infiltration and differentiation in spheroids generated from fibroblasts and either of the cancer cell lines MCF-7, HT-29, PANC-1, or MIA PaCa-2. Monocytes rapidly infiltrated spheroids and differentiated into mature macrophages with diverse phenotypes in a cancer cell line-dependent manner. MIA PaCa-2 spheroids polarized infiltrating monocytes to M2-like macrophages with high CD206 and CD14 expression, whereas monocytes polarized by MCF-7 spheroids displayed an M1-like phenotype. Monocytes in HT-29 and PANC-1 primarily obtained an M2-like phenotype but also showed upregulation of M1 markers. Analysis of the secretion of 43 soluble factors demonstrated that the cytokine profile between spheroid cultures differed considerably depending on the cancer cell line. Secretion of most of the cytokines increased upon the addition of monocytes resulting in a more inflammatory and pro-tumorigenic environment. These multicellular spheroids can be used to recapitulate the tumor microenvironment and the phenotype of tumor-associated macrophages in vitro and provide more realistic 3D cancer models allowing the in vitro screening of immunotherapeutic compounds.
Open AccessMonocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer Models
Tumor-associated macrophages often correlate with tumor progression, and therapies targeting immune cells in tumors have emerged as promising treatments. To select effective therapies, we established an in vitro 3D multicellular spheroid model including cancer cells, fibroblasts, and monocytes. We analyzed monocyte infiltration and differentiation in spheroids generated from fibroblasts and either of the cancer cell lines MCF-7, HT-29, PANC-1, or MIA PaCa-2. Monocytes rapidly infiltrated spheroids and differentiated into mature macrophages with diverse phenotypes in a cancer cell line-dependent manner. MIA PaCa-2 spheroids polarized infiltrating monocytes to M2-like macrophages with high CD206 and CD14 expression, whereas monocytes polarized by MCF-7 spheroids displayed an M1-like phenotype. Monocytes in HT-29 and PANC-1 primarily obtained an M2-like phenotype but also showed upregulation of M1 markers. Analysis of the secretion of 43 soluble factors demonstrated that the cytokine profile between spheroid cultures differed considerably depending on the cancer cell line. Secretion of most of the cytokines increased upon the addition of monocytes resulting in a more inflammatory and pro-tumorigenic environment. These multicellular spheroids can be used to recapitulate the tumor microenvironment and the phenotype of tumor-associated macrophages in vitro and provide more realistic 3D cancer models allowing the in vitro screening of immunotherapeutic compounds.
- 24 June 2021
- Published by Springer Nature
- Vol. 2348, 123-137
Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids
Cancer cell spheroids are considered important preclinical tools to evaluate the efficacy of new drugs. In cancer cell spheroids, the cells assemble and grow in 3D structures with cell contact interactions that are partly impermeable, which leads to central hypoxia and necrosis. The cell spheroids thus possess several features identified in clinical tumors. Not only will the effect and behavior of therapeutic drugs in 3D cell spheroids be affected more similarly than in cells grown on culture plates, but molecular interactions and signaling pathways in cells are also more likely to mimic the in vivo situation. The monitoring of various biomarkers including lncRNAs in 3D cell spheroids is important to assess a potentially induced phenotype in the cells and the effects of drugs. Specifically, for lncRNAs, in situ localization can be done using locked nucleic acid (LNA) probe technology. Here we present a protocol for preparation of cell spheroids for use in LNA probe–based in situ hybridization to study lncRNA expression in paraffin embedded 3D cancer cell spheroids.
- 24 June 2021
- Published by Springer Nature
- Vol. 2348, 123-137
Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids
Cancer cell spheroids are considered important preclinical tools to evaluate the efficacy of new drugs. In cancer cell spheroids, the cells assemble and grow in 3D structures with cell contact interactions that are partly impermeable, which leads to central hypoxia and necrosis. The cell spheroids thus possess several features identified in clinical tumors. Not only will the effect and behavior of therapeutic drugs in 3D cell spheroids be affected more similarly than in cells grown on culture plates, but molecular interactions and signaling pathways in cells are also more likely to mimic the in vivo situation. The monitoring of various biomarkers including lncRNAs in 3D cell spheroids is important to assess a potentially induced phenotype in the cells and the effects of drugs. Specifically, for lncRNAs, in situ localization can be done using locked nucleic acid (LNA) probe technology. Here we present a protocol for preparation of cell spheroids for use in LNA probe–based in situ hybridization to study lncRNA expression in paraffin embedded 3D cancer cell spheroids.